BioForce Ships Five Nano eNabler(TM) Systems in Third Quarter

Sep 26, 2006, 01:00 ET from BioForce Nanosciences, Inc.

    AMES, Iowa, Sept. 26 /PRNewswire-FirstCall/ -- BioForce Nanosciences,
 Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
 (OTC Bulletin Board:   BFNH.OB), shipped five of its core technology Nano
 eNabler(TM) molecular printing systems to customers in the U.S. and Canada
 in the third quarter, the Company announced. Under its previously announced
 product placement program, BioForce plans on shipping up to 20 Nano eNabler
 systems to prestigious domestic and international biomedical and life
 science research facilities by year end. In consideration of a license to
 use the Nano eNabler system to research applications, the facilities agree
 to provide BioForce with feedback on the performance and applications of
 the instrumentation.
     The BioForce Nano eNabler system prints tiny domains of biological
 materials on surfaces with nanometer spatial precision. The BioForce
 instrument prints biomaterial sample sizes ranging from one to 20 microns
 -- about 20 billion times smaller than a drop of blood -- allowing
 researchers to investigate the development of new biomedical applications.
     "During May of this year BioForce installed four Nano eNabler systems,
 two in the U.S. and two overseas. We have integrated a comprehensive
 installation, training and follow-up support process for the Nano eNabler
 technology, moving our customers through a short learning curve," said
 Michael Lynch, Product Manager. "The three devices shipped in August have
 been installed successfully and customer training completed. Two additional
 units have shipped with installation planned for October."
     "For the remainder of the year BioForce anticipates shipping an
 additional eleven systems bringing this total to 20 Nano eNabler system
 shipments for 2006," said Kerry Frey, BioForce Chief Operations Officer.
     "Our manufacturing team is actively building systems to meet our
 production goals," said Curtis Mosher, founder and Vice President of
 Research and Development. "I am pleased with how the Company has integrated
 the process encompassing inventory, build, installation, training and
 customer support."
     About BioForce Nanosciences, Inc.
     BioForce Nanosciences is a nanotechnology tools and applications
 company, providing innovative and practical products that support the
 growth of the nanotechnology industry. The Company has spent more than a
 decade of invention, research and development on patented and
 patent-pending nanotechnology products. The core technology is the Nano
 eNabler(TM) benchtop molecular printer, a portal to new opportunities in
 nanotechnology. The Nano eNabler system uses microfluidic surface
 patterning tools to print biomaterials that are one to 20 microns in size.
 The Nano eNabler system opens the door to new and important applications in
 the biomedical and life sciences markets that lead to improved quality of
 life. BioForce continues to target inventions that further expand the reach
 of its proprietary technology and expand its robust patent, trademark and
 IP portfolio.
     BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) Company,
 brings inventions to the marketplace that complement existing innovations,
 licensing and acquisitions. BioForce is a wholly owned subsidiary of
 BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board:   BFNH.OB). For
 more information, visit
     This news release contains forward-looking information that may be
 affected by certain risks and uncertainties, including those risks and
 uncertainties described in the Company's most recent filings with the
 Securities and Exchange Commission. The Company's actual results could
 differ materially from such forward-looking statements. We assume no duty
 to update these statements at any future date.

SOURCE BioForce Nanosciences, Inc.